Valneva SE (VALN)

Nasdaq Biotechnology Diagnostics SIC: 2836
D
Pipeline Grade

Drug Pipeline (0 Assets)

No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.

Upcoming Catalysts

No upcoming catalysts detected for this company.

Active Clinical Trials (3)

NCT #TitlePhaseStatusEnrollment
NCT07347002 Observational Study to Assess the Effectiveness of VLA1553 Vaccine in Preventing Chikungunya During a Pilot Vaccination ... OTHER Enrolling By Invitation 1,200
NCT07163845 Assessment of Chikungunya Virus Seroprevalence Before VLA1553 Vaccination in the Municipalities Selected for Participati... OTHER Active Not Recruiting 5,354
NCT07254702 Prospective Safety Cohort Study After VLA1553 Vaccination in Municipalities Selected for Participation in the VLA1553 Pi... OTHER Enrolling By Invitation 5,000

Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.

More Analysis